Patriot Financial Group Insurance Agency, LLC Rigel Pharmaceuticals Inc Transaction History

Patriot Financial Group Insurance Agency, LLC

  • $720 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 07, 2019
SELL
$2.02 - $2.61 $606 - $783
-300 Closed
0 $0
Q3 2018

Oct 30, 2018
BUY
$2.6 - $3.59 $780 - $1,077
300 New
300 $1,000
Q2 2018

Aug 14, 2018
SELL
$2.83 - $4.11 $849 - $1,233
-300 Closed
0 $0
Q2 2017

Aug 08, 2017
BUY
N/A
300
300 $1,000

Others Institutions Holding RIGL

# of Institutions
9
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.81B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email